Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details)

v3.24.3
NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Percentage of common stock outstanding, issuable 9.90%   9.90%  
Grants of RSUs with service only (i.e., time-vesting) conditions        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 811,664 1,489,987 811,664 1,204,350
Common stock issuable under the Backstop Notes        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 1,920,007 1,920,007 1,920,007 1,920,007
Private placement warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 272,779 272,779 272,779 272,779